483
Rogerio LoboRogerio Lobo – FDA 483
Record Details
An FDA inspection of Rogerio A. Lobo, M.D. at Columbia University Medical Center in New York revealed significant deficiencies in sponsor oversight of an investigational new drug (IND) study. The firm failed to submit annual reports, adequately monitor clinical investigators, ensure investigator qualifications, and maintain control over the investigational drug. These failures led to issues with adverse event reporting and overall study compliance.
- Company
- Rogerio Lobo
- Product type
- drugs
View Company Profile
ID · d9cf25ab-c433-45d7-b046-0a90f9c819aa
Other documents for Rogerio Lobo
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.